Several diseases, including cancer, neurodegenerative diseases, autoimmune diseases, infectious diseases and vitiligo, are caused by a loss of control over single or combined modes of cell death
Most patients experience noticeable weight loss within the first few weeks of starting their program
LIP-C dosing is determined by a prescribing provider based on indication, individual factors, and tolerability
Complementary clinical and meta-analytic data consistently demonstrate systemic redox imbalance, including lower glutathione reserves, altered GSH/GSSG ratios, increased lipid peroxidation, and dysregulated NRF2 signaling, linking oxidative status to immune activation and synaptic dysfunction (James et al., 2004